IP Library Granted Patent US 7,172,890
Granted Patent B2
US 7,172,890 · App. 10/975,697 · Granted Feb 6, 2007

Inactivated enzyme variants and associated process and reagent system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,172,890
App. No.
10/975,697
Granted
Feb 6, 2007
Kind
B2
Abstract

The present invention relates to oxidoreductase apoenzyme variants which are enzymatically inactive but have coenzyme-binding properties. Further, the present invention relates to DNA sequences encoding these oxidoreductase apoenzyme variants, expression vectors containing such DNA sequences and the use of these oxidoreductase apoenzyme variants in diagnostic applications.

Claims (9)

1. A glucose dehydrogenase variant having about 3% or less residual enzymatic activity relative to the wild type enzyme and which retains about 20% or more of the coenzyme binding activity of the wild type enzyme, wherein said variant comprises an amino acid substitution at position 145 or 158 of the amino acid sequence of SEQ ID NO: 6 of B. subtilis.

2. The glucose dehydrogenase variant as claimed in claim 1 , wherein the coenzyme is NAD(P)H.

3. The glucose dehydrogenase variant as claimed in claim 1 which has a threonine substitution at position 145 or a phenylalanine substitution at position 158 of the amino acid sequence of SEQ ID NO: 6 of B. subtilis.

4. The glucose dehydrogenase variant as claimed in claim 3 , having fused thereto an amino acid segment capable of forming a metal chelate.

5. The glucose dehydrogenase variant as claimed in claim 4 , wherein the amino acid sequence of said variant comprises the sequence of SEQ ID NO: 14.

6. A glucose dehydrogenase variant comprising the amino acid sequence as shown in SEQ ID NO: 8.

7. The glucose dehydrogenase of claim 6 further comprising an amino acid sequence fused thereto that is capable of forming a metal chelate.

8. A glucose dehydrogenase variant comprising the amino acid sequence as shown in SEQ ID NO: 10.

9. The glucose dehydrogenase of claim 8 further comprising an amino acid sequence fused thereto that is capable of forming a metal chelate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →